California Institute of Technology (Caltech)United States
Andrew M. Stuart is a Professor at the California Institute of Technology's Division of Engineering and Applied Science. His research bridges computational mathematics, machine learning, and physical modeling, focusing on inverse problems, partial differential equations, and multiscale systems. He has pioneered methodologies integrating Gaussian processes, Kalman inversion, and neural operators for scientific computing. His recent publications highlight innovations in competitive protein dimerization networks, nonlinear Bayesian inference, and operator learning. Articles span applications in materials science, geophysics, and biochemical signal processing, emphasizing data-driven discovery of differential equations and scalable algorithms for high-dimensional problems. Stuart's work addresses challenges in structural error modeling, uncertainty quantification, and graph-based learning, with implications for climate modeling and dynamical systems. Despite extensive contributions, the scraped data does not specify students, awards, or contact details.
Wengong Jin is an Assistant Professor at the Khoury College of Computer Sciences, Northeastern University, and a visiting research scientist at the Eric and Wendy Schmidt Center at the Broad Institute. He holds a PhD from MIT CSAIL, advised by Prof. Regina Barzilay and Prof. Tommi Jaakkola. Research Interests: His work focuses on geometric and generative AI models for drug discovery, biology, and chemical engineering. Key areas include equivariant neural networks (e.g., FAFormer), diffusion models for binding energy prediction, antibody/enzyme design (RefineGNN, SurfPro), and molecular design through graph neural networks (Junction Tree VAE). He also explores domain generalization and systems for autonomous molecular discovery. Publications: His research has been published in top venues like NeurIPS, ICLR, ICML, Nature, Science, and Cell. Recent breakthroughs include discovering novel antibiotics using explainable AI and designing synergistic drug combinations for cancer treatment. Awards: He has received the BroadIgnite Award, Dimitris N. Chorafas Prize, and MIT EECS Outstanding Thesis Award for his contributions to computational biology and AI-driven drug discovery. Teaching: Currently teaches a PhD seminar on AI for Science, focusing on integrating machine learning into scientific discovery processes.
John M. Woodley is a distinguished Professor in the Department of Chemical and Biochemical Engineering at the Technical University of Denmark (DTU), where he leads research at the PROSYS - Process and Systems Engineering Centre and contributes to the DTU Microbes Initiative. With over 30 years of experience, he has established himself as a leading expert in biocatalysis and bioprocess engineering, with research spanning both theoretical and experimental work across multiple scales. His primary research interests focus on the interface of bioprocess engineering, process chemistry, and reaction engineering. Dr. Woodley's work encompasses multi-step biocatalysis (including systems biocatalysis and flow chemistry), downstream processing from biocatalytic reactors and fermentations (including ISPR), modeling tools for bioprocess assessment (thermodynamics, kinetics, process simulation, economic evaluation), and bio-oxidations (including oxygen supply methods). His enzymatic investigations particularly target alcohol oxidases, carbohydrate oxidases, cytochrome P450s, Baeyer-Villiger monooxygenases, and transaminases. His research portfolio demonstrates consistent innovation in sustainable chemical production, with particular emphasis on enzymatic synthesis of pharmaceuticals and chemicals from renewable resources. Analysis of his recent publications reveals a strong focus on overcoming industrial implementation challenges, particularly regarding enzyme stability in various reactor environments, optimization of multi-enzyme systems, and scale-up methodologies for biocatalytic processes. Dr. Woodley actively supervises multiple PhD students and leads several significant research projects, including 'P450-based biocatalytic processes for the pharmaceutical industry' (2025-2028), 'Integrated model for up- and downstream bioprocess intensification' (2024-2027), and 'ENFACE: A tool for prediction of enzyme stability at gas-liquid interfaces' (2024-2027). His work has resulted in an impressive publication record of 781 research outputs across various formats, including journal articles, book chapters, and conference proceedings. His research group operates within the Department of Chemical and Biochemical Engineering at DTU, utilizing advanced facilities for biocatalysis research, including specialized reactor systems for studying gas-liquid interfaces, computational modeling resources, and laboratories for enzyme characterization and bioprocess development. Through his leadership in the PROSYS center, he contributes to DTU's strategic focus on sustainable process technologies and systems engineering.
David R. Koes is an Associate Professor in the Department of Computational and Systems Biology at the University of Pittsburgh, affiliated with the School of Medicine. He holds roles such as Associate Director of the Joint CMU-Pitt Computational Biology PhD Program (CPCB) and is involved in multiple graduate programs including Intelligent Systems and Computational Biomedicine. His research focuses on developing computational algorithms and systems for drug discovery, emphasizing open-source software and machine learning applications in biomedical data. Koes teaches courses like MSCBIO2025 (Bioinformatics Programming in Python) and MSCBIO2065 (Scalable Machine Learning for Big Data Biology). He has secured NIH funding (R35GM140753) and collaborated on projects with institutions like NVIDIA and Google Cloud. His lab develops tools such as GNINA, Pharmit, and 3Dmol.js, and actively contributes to open drug discovery initiatives. Education: PhD in Computer Science from Carnegie Mellon University (CMU). Research Interests: Leveraging computation and AI for drug design, molecular docking, pharmacophore modeling, and open science. Specific areas include developing scalable machine learning pipelines, virtual screening systems, and tools for 3D molecular analysis. Grants and Funding: Current NIH R35 grant and prior support from NSF, Relay Therapeutics, and others. His work emphasizes translating computational methods into practical drug discovery solutions. Lab and Teams: Directs a lab focused on computational drug discovery, collaborating with multiple academic and industry partners. Supervises graduate students and postdocs in projects spanning AI-driven drug design, molecular modeling, and software development.
University of California, Los AngelesUnited States
Dr. Steven G. Clarke is a Distinguished Professor at UCLA Department of Chemistry & Biochemistry and director of research at the Molecular Biology Institute . His work bridges protein chemistry , methylation biology , and aging research through studies of spontaneous protein damage and its repair mechanisms. Education: BA in Chemistry and Zoology, Pomona College (magna cum laude, Phi Beta Kappa) PhD in Biochemistry and Molecular Biology, Harvard University (NSF Fellow) Postdoctoral Fellowship at UC Berkeley (Miller Fellow) Dr. Clarke's research focuses on protein isoaspartyl repair via PCMT1/PIMT enzymes , ribosomal protein methylation in Saccharomyces cerevisiae , and PRMT family characterization including PRMT7 and PRMT9. His lab combines biochemical assays , genetic models , and structural analysis to investigate aging mechanisms and disease implications. Recent publications highlight: COQ5 structure-function analysis in coenzyme Q biosynthesis PCMTD1 ubiquitin ligase interactions PRMT7 substrate specificity in histone H2B Protein isoaspartyl impacts on T cell function in lupus Novel PRMT inhibitors for cancer therapy Methionine addiction in osteosarcoma malignancy Major scientific awards: American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NIH MERIT Award Ellison Medical Foundation Senior Scholar Award William C. Rose Award, ASBMB UCLA Distinguished Teaching Award (Eby Award winner) Current lab members include PhD candidates Eric Pang (UCSB) and Sining "Cindy" Wang (UCLA), while undergraduates Celeste Medina-Seymoure , Elizabeth Oroudjeva , Olivia Pacheco , and Jasmine Winter contribute to ongoing proteostasis studies. Collaborations with Profs. Jose Rodriguez and Catherine Clarke demonstrate interdisciplinary research approaches.
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
University of California, Los AngelesUnited States
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Dewey G. McCafferty is Professor of Chemistry at Duke University with appointments in Biochemistry and the Duke Cancer Institute. His research focuses on chemical biology of chromatin-modifying enzymes and ubiquitin signaling pathways relevant to neurodegeneration and infection. Notable work includes discovering the lasso peptide antibiotic Arcumycin, characterizing the Nedd4 ubiquitin ligase in Parkinson's disease models, and developing chemoproteomic approaches for target identification. Key contributions include elucidation of the futalosine pathway in Chlamydia infections, mechanisms of CPAF protease in bacterial pathogenesis, and engineering of histone demethylase enzymes. McCafferty received the Eli Lilly Award in Biological Chemistry (2005) and directs NIH-funded projects on ubiquitin ligases in neurodegeneration.
University of Illinois Urbana-ChampaignUnited States
Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.
Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .
Pengtao Xie is an Associate Professor (with tenure as of June 2025) in the Department of Electrical and Computer Engineering at the University of California San Diego. He also serves as Associate Adjunct Professor in the Division of Biomedical Informatics, Department of Medicine, and holds affiliate appointments with the Halıcıoğlu Data Science Institute, School of Biological Sciences, Shu Chien-Gene Lay Department of Bioengineering, Skaggs School of Pharmacy and Pharmaceutical Sciences, and multiple research institutes including the AI Group, Center for Machine-Intelligence, Computing and Security, Institute of Engineering in Medicine, and Institute for Genomic Medicine. Education: PhD in Machine Learning, School of Computer Science, Carnegie Mellon University Research Interests: His research focuses on machine learning inspired by human learning skills, such as self-explanation, small-group learning, and learning by teaching. He applies these techniques to large language models, foundation models, healthcare, and biomedicine. His work spans generative AI, medical imaging, protein modeling, and drug discovery. Recent Research Trends: His 2024–2025 publications emphasize generative AI for ultra-low-data medical image segmentation, multimodal large language models for biomedical applications, protein function prediction, and novel training strategies like task-adaptive pretraining and bi-level optimization for model adaptation. Scientific Awards: NIH MIRA Award (2025) NSF CAREER Award (2024) Best Graduate Teacher Award – UCSD ECE (2023) ICLR Notable-Top-5% Paper (2023) Global Top-100 Chinese Young Scholars in AI (2022) UCSD Faculty Career Development Award (2022) Tencent Faculty Award (2021) Outstanding Reviewer – ICLR (2021) AMIA Doctoral Dissertation Award Finalist (2020) Amazon AWS Research Award (2020) Tencent AI-Lab Faculty Award (2020) Innovator Award – Pittsburgh Business Times (2018) Siebel Scholarship (2014) Advising and Grants: He currently advises PhD students, postdocs, and master’s students. He has received major grants including the NIH MIRA and NSF CAREER awards, and actively mentors Schmidt AI in Science postdocs and graduate students. Teaching and Labs: He teaches ECE285 Deep Generative Models and ECE175B Probabilistic Reasoning and Graphical Models . His lab focuses on foundational and translational AI research with applications in biomedicine and healthcare.
Rex Ying is an Assistant Professor in the Department of Computer Science at Yale University's School of Engineering & Applied Science. He leads research in graph neural networks, geometric representation learning, and explainable AI, with applications spanning physical simulations, biology, knowledge graphs, and recommender systems. His lab actively recruits PhD students interested in geometric deep learning, graph neural networks, and trustworthy AI. Dr. Ying received his PhD in Computer Science from Stanford University under Jure Leskovec, with a thesis titled "Towards Expressive and Scalable Deep Representation Learning for Graphs." Prior to that, he graduated from Duke University in 2016 with highest distinction, majoring in Computer Science and Mathematics. His research focuses on three interconnected areas: advancing graph neural network architectures for improved expressiveness, scalability, and interpretability; innovating in geometric representation learning for data with diverse characteristics; and developing real-world applications across scientific domains. He has pioneered influential algorithms including GraphSAGE, PinSAGE, and GNNExplainer, and developed the first billion-scale graph embedding services at Pinterest as well as graph-based anomaly detection algorithms at Amazon. His recent publication trends show a strong focus on hyperbolic geometry for foundation models, non-Euclidean representation learning, and multimodal applications in computational biology. The research demonstrates increasing integration of geometric deep learning with large language models and foundation model architectures. KDD 2022 Dissertation Award 2019 Baidu Scholarship in Artificial Intelligence Dr. Ying actively serves the research community as a committee member for major conferences including AAAI, ICML, NeurIPS, ICLR, KDD, and WebConf for over seven years, and as area chair for LoG 2022. He co-leads the open-source PyTorch Geometric project and has organized numerous workshops on graph learning. His industry collaborations include Pinterest, Amazon, Facebook AI Research, DeepMind, Siemens, SLAC National Accelerator Laboratory, and Saudi Aramco. He teaches "Deep Learning for Graph-Structured Data" at Yale and mentors students in developing cutting-edge graph learning algorithms. His research lab collaborates with both academic institutions and industry partners to advance the state-of-the-art in graph representation learning, with particular emphasis on geometric deep learning and its applications to scientific discovery and real-world systems.
Dr. Vincent Fortuin is a tenure-track Assistant Professor at the Technical University of Munich (TUM) and a research group leader at Helmholtz AI in Munich. He leads the Efficient Learning and Probabilistic Inference for Science (ELPIS) group and holds multiple prestigious fellowships including the Branco Weiss Fellowship. His academic affiliations include the TUM School of Computation, Information and Technology, the Konrad Zuse School of Excellence in Reliable AI, and the Munich Center for Machine Learning. Dr. Fortuin earned his BSc in Molecular Life Sciences from the University of Hamburg (2012-2015), followed by an MSc in Computational Biology and Bioinformatics from ETH Zürich (2015-2017), where he received the ETH Excellence Scholarship and the Willi Studer Prize. He completed his PhD in Machine Learning at ETH Zürich (2017-2021) under the supervision of Gunnar Rätsch and Andreas Krause, supported by a Swiss Data Science Center PhD Fellowship. Prior to joining TUM, he was a Research Fellow at St. John's College, University of Cambridge (2022-2023). His research focuses on the intersection of Bayesian statistics and deep learning, specifically developing methods for more robust, data-efficient AI systems with reliable uncertainty estimates. His work addresses critical limitations in standard deep learning approaches, particularly their tendency to be overconfident in predictions and require large datasets for training. He investigates better priors and more efficient inference techniques for Bayesian deep learning, deep generative modeling, meta-learning, and PAC-Bayesian theory, with applications in scientific and biomedical domains. Dr. Fortuin's recent publications demonstrate a consistent focus on improving uncertainty quantification in deep learning systems, with increasing emphasis on practical applications in scientific contexts. His work spans from theoretical foundations of Bayesian deep learning to practical implementations in protein design, materials science, and medical applications. A notable trend is his exploration of how to make Bayesian methods more scalable and applicable to modern large-scale AI systems while maintaining theoretical guarantees. Branco Weiss Fellowship (2023) St John's College Research Fellowship (2022) Swiss National Science Foundation Postdoc.Mobility Fellowship (2022) Swiss Data Science Center PhD Fellowship (2018) ETH Excellence Scholarship (2015) Willi Studer Award (2018) Dr. Fortuin actively supervises PhD and Master's students through his ELPIS research group at Helmholtz AI. He serves as a regular reviewer and area chair for major machine learning conferences and is an action editor for TMLR. He co-organizes the Symposium on Advances in Approximate Bayesian Inference (AABI) and the ICBINB initiative, demonstrating his commitment to advancing the field through community building. His research group receives funding from multiple sources including Helmholtz AI, the Branco Weiss Fellowship, and collaborations with international institutions. Dr. Fortuin leads the Efficient Learning and Probabilistic Inference for Science (ELPIS) group at Helmholtz AI, which focuses on fundamental machine learning research motivated by real-world scientific problems. The group collaborates extensively with researchers across Helmholtz centers and international institutions, particularly in biomedical applications where reliable uncertainty estimates are crucial.
Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.
Zoran Cenev holds a Tenure Track Assistant Professor position within the Mechatronics and Dynamics section of the Department of Mechanical and Production Engineering at the School of Engineering, Aarhus University. His primary institutional affiliation is with AU Engineering, and contact details include email zoran.cenev@mpe.au.dk and telephone +45 20 64 75 44, with office location Aarhus N, 5128-140. Research interests focus on interdisciplinary applications of magnetic and robotic systems: Robotic micromanipulation via electromagnetic needles Ferrofluid-based biofabrication for skeletal muscle engineering Laser-induced photothermal droplet control Theoretical modeling of particle dynamics at fluid interfaces Surface engineering for underwater metallic stability Nanostructure formation through ion bombardment His recent publications (2023-2025) reveal a dominant trend in adapting ferrofluids for biomedical automation, particularly 3D bioprinting of magnetically responsive tissues and droplet manipulation on engineered surfaces. This work bridges mechanical engineering with regenerative medicine, emphasizing practical implementations of theoretical models for microscale precision. Scientific awards are not documented in the provided information. As a faculty member, Dr. Cenev likely mentors graduate students and pursues research grants, though specific advisees or funding details are absent. Departmental laboratories and workshops support his experimental work in mechatronics, with emphasis on magnetic manipulation systems and surface characterization.
